Double-Blind Comparison of Bromocriptine and Placebo in Cocaine Withdrawal

References

• Dackis C. A., Gold M. S., Davies R. K., Sweeney D. R. Bromocriptine treatment for cocaine abuse: The dopamine depletion hypothesis. Int. J. Psychiatry Med. 1985; 15(2)125–135
   PubMed Web of Science ®Google Scholar
• Gold M. S., Washton A. M. Cocaine abuse: Neurochemistry, phenomenology, and treatment. Cocaine Use in America: Epidemiologic and Clinical Perspectives, N. J. Koze, E. H. Adams. NIDA Research Monograph Series, No. 61, National Institute on Drug Abuse, Rockville, Maryland 1985
   Google Scholar
• Olds J. Pleasure centers in the brain. Set. Am. 1956; 195: 105–116
   Web of Science ®Google Scholar
• Goeders N. E., Smith J. E. Critical dopaminergic involvement in cocaine reinforcement. Science 1983; 221: 773–775
   PubMed Web of Science ®Google Scholar
• DeWitt H., Wise R. A. A blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can. J. Psychol. 1977; 31: 195–203
   PubMed Web of Science ®Google Scholar
• Taylor D., Ho B. T., Fagen J. D. Increased dopamine receptor binding in rat brain by repeated cocaine injections. Commun. Psychopharmacol. 1979; 3: 137–142
   PubMedGoogle Scholar
• Taylor D., Ho B. T. Neurochemical effects of cocaine following acute and repeated injection. J. Neurosci. Res. 1977; 3: 95–101
   PubMed Web of Science ®Google Scholar
• Dackis C. A., Gold M. S. Bromocriptine as treatment for cocaine abuse. Lancet May 18, 1985; 1151–1152
   PubMed Web of Science ®Google Scholar
• Tennant F. S., Sagherian A. A. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch. Intern. Med. 1987; 147: 109–112
   PubMed Web of Science ®Google Scholar
• Dackis C. A., Gold M. S., Estroff T. W., Sweeney D. R. Hyperprolactinemia in cocaine abuse. Soc. Neurosci. Abst. 1984; 10: 1099
   Google Scholar
• Dackis C. A., Gold M. S. Neurotransmitter and neuroendocrine abnormalities associated with cocaine use. Psychiatr. Med. 1987; 3(4)472–473
   Google Scholar
• Mendelson J. H., Teoh S. K., Lange U., Mello N. K., Weiss R., Skuphy A., Ellingboe J. Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am. J. Psychiatry 1988; 145(9)1094–1098
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Kleber H. D. Neuroendocrine findings in chronic cocaine abusers: A preliminary report. Br. J. Psychiatry 1985; 147: 569–572
   PubMed Web of Science ®Google Scholar
• Swartz C. M., Breen K., Leone F. Serum prolactin levels during extended cocaine abstinence. Am. J. Psychiatry 1990; 147(6)777–779
   PubMed Web of Science ®Google Scholar
• MacLeod R. M. Regulation of prolactin secretion. Frontiers in Neuroendocrinology, L. Martin, W. F. Ganong. Raven Press, New York 1976; 169–194
   Google Scholar
• Morgan H. E. Endocrine control system. Best and Taylor's Physiologic Basis of Medical Practice, 9th ed., J. R. Brobeck. Williams and Wilkins Press, Baltimore 1973; 8–28; 143–145
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. Washington, DC 1987
   Google Scholar
• Deragotis L. R. SCL-90-R Administration, Scoring and Procedures Manual. John Hopkins School of Medicine, Clinical Psychometrics Research Unit. 1977
   Google Scholar
• Beck A. T., Ward C. H., Mendelson M. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–571
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry 1986; 43: 107–113
   PubMed Web of Science ®Google Scholar
• Gawin F. H. Chronic neuropharmacology of cocaine: Progress in pharmacotherapy. J. Clin. Psychiatry 1988; 49(2)11–16, (Suppl.)
   PubMedGoogle Scholar
• Extein I., Gross D. A., Gold M. S. Bromocriptine treatment of cocaine withdrawal symptoms. Am. J. Psychiatry 1989; 146(3)403
   PubMed Web of Science ®Google Scholar
• Guenther W. C. Analysis of Variance. Prentice-Hall, Englewood Cliffs, New Jersey 1964; 143–164
   Google Scholar
• Howell D. C. Statistical Methods for Psychology, 2nd ed. Duxbury Press, Boston 1987; 539
   Google Scholar
• Brower K. J., Maddahian E., Blow F. C., Beresford T. P. A comparison of self-reported symptoms and DSM-III-R criteria for cocaine withdrawal. Am. J. Drug Alcohol Abuse 1988; 14(3)347–356
   PubMed Web of Science ®Google Scholar
• Giannini A. J., Baumgarter P., DiMarzio L. Bromocriptine therapy in cocaine withdrawal. J. Clin. Pharmacol. 1987; 27: 267–270
   PubMed Web of Science ®Google Scholar
• Teller D. W., Devenyi P. Bromocriptine in cocaine withdrawal-Does it work. Int. J. Addict. 1988; 23(11)1197–1205
   PubMed Web of Science ®Google Scholar
• Dackis C. A., Gold M. S., Sweeney D. R., Byron J. P., Jr., Climko R. Single-dose bromocriptine reverses cocaine craving. Psychiatr. Res. 1987; 20: 261–264
   PubMed Web of Science ®Google Scholar
• Giannini A. J., Folts D. J., Feather J. N., Sullivan B. S. Bromocriptine and amantadine in cocaine detoxification. Psychiatr. Res. 1989; 29: 11–16
   PubMed Web of Science ®Google Scholar